ArriVent BioPharma Inc — 財務諸表 (NASDAQ:AVBP) | MetaTrader

チャート全体を表示

ニュース

Are Medical Stocks Lagging AstraZeneca (AZN) This Year?

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

ArriVent BioPharma: Phase 3 Delay May Signal Stronger Outcomes For Firmonertinib (NASDAQ:AVBP)

BTIGがArriVent株のカバレッジを開始、腫瘍学パイプラインを評価し買い推奨

BTIG initiates ArriVent stock coverage with buy rating on oncology pipeline

Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Cantor Fitzgerald、ArriVent株式をオーバーウェイト評価で据え置き

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

オッペンハイマー、ArriVent BioPharmaの株式に「アウトパフォーム」評価を維持

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy